Liver Function as a Determinant of Antioxidant Therapeutic Efficacy in Benign Prostatic Hyperplasia: A Systems Biology Perspective
Abstract
Benign Prostatic Hyperplasia (BPH) is a non-malignant enlargement of the prostate gland predominantly affecting aging males. While oxidative stress (OS) is recognized as a key pathogenic driver in BPH, emerging evidence highlights the liver’s critical role in modulating systemic redox homeostasis and influencing antioxidant therapeutic responses. Liver function not only governs the bioavailability, metabolism, and clearance of antioxidant compounds but also contributes to systemic inflammation and metabolic alterations that exacerbate BPH pathophysiology. This review adopts a systems biology approach to explore the complex liver-prostate axis, emphasizing how liver health determines the pharmacokinetics, pharmacodynamics, and therapeutic efficacy of antioxidant interventions in BPH management. We discuss the molecular mechanisms underpinning hepatic regulation of antioxidant bioactivity, the impact of liver dysfunction on BPH progression, and emerging therapeutic strategies aimed at restoring liver-prostate homeostasis. Future research directions advocate for precision antioxidant therapy guided by liver function biomarkers, systems biology modeling, and integrative metabolic profiling.
Keywords: Benign Prostatic Hyperplasia; Liver Function; Antioxidant Therapy; Oxidative Stress; Systems Biology
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.